Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Becton, Dickinson and Company, commonly known as BD, is a large publicly traded medical technology company focused on medical supplies, instruments, diagnostic products, life sciences tools, and drug-delivery systems. Its businesses span medication management, vascular access, interventional products, specimen collection, microbiology and molecular diagnostics, biosciences research tools, and prefillable delivery systems for biologics and pharmaceuticals. The company serves hospitals, physicians, clinical laboratories, life science researchers, and pharmaceutical manufacturers worldwide. BD is not a therapeutic biotech developer with a traditional drug pipeline; instead, it is primarily a commercial-stage medtech and diagnostics company with broad healthcare infrastructure and product portfolios.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dickson and Company.